Figure 1.
IL-6 magnifies the inflammatory response through its soluble receptor. Release of the sIL-6R acts to amplify the inflammatory response by making cells lacking mIL-6R responsive to IL-6. The resulting sustained inflammatory response paves way for the progression from acute to chronic inflammation and could ultimately lead to colitis-associated cancer.